BI 409306 studied in cognition in sz phase 2, but how did it do?

Hate it when the trials end and then there is no news.

2 Likes

What is it? I’m not sure if I need a med for cognitive symptoms.

It is a PDE9A inhibitor being tested for treatment of cognitive impairment in Alzheimers and sz.

1 Like

Agree that it’s frustrating.

1 Like

Just guessing the results weren’t great, otherwise why not release them and get a stock price boost. But no way to know for sure.

This sounds like some real heavy ■■■■.
Maybe they’re keeping it under wraps until they know for sure.